PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BSVO vs. EBS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BSVO and EBS is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

BSVO vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EA Bridgeway Omni Small-Cap Value ETF (BSVO) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025
29.89%
18.05%
BSVO
EBS

Key characteristics

Sharpe Ratio

BSVO:

0.32

EBS:

3.40

Sortino Ratio

BSVO:

0.63

EBS:

3.82

Omega Ratio

BSVO:

1.08

EBS:

1.53

Calmar Ratio

BSVO:

0.61

EBS:

5.56

Martin Ratio

BSVO:

1.41

EBS:

17.47

Ulcer Index

BSVO:

4.98%

EBS:

31.49%

Daily Std Dev

BSVO:

21.49%

EBS:

162.27%

Max Drawdown

BSVO:

-12.52%

EBS:

-98.89%

Current Drawdown

BSVO:

-6.68%

EBS:

-91.66%

Returns By Period

In the year-to-date period, BSVO achieves a 1.39% return, which is significantly lower than EBS's 17.68% return.


BSVO

YTD

1.39%

1M

1.25%

6M

5.01%

1Y

10.80%

5Y*

N/A

10Y*

N/A

EBS

YTD

17.68%

1M

9.01%

6M

11.28%

1Y

594.44%

5Y*

-28.39%

10Y*

-7.81%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BSVO vs. EBS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSVO
The Risk-Adjusted Performance Rank of BSVO is 1818
Overall Rank
The Sharpe Ratio Rank of BSVO is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of BSVO is 1515
Sortino Ratio Rank
The Omega Ratio Rank of BSVO is 1414
Omega Ratio Rank
The Calmar Ratio Rank of BSVO is 2929
Calmar Ratio Rank
The Martin Ratio Rank of BSVO is 1818
Martin Ratio Rank

EBS
The Risk-Adjusted Performance Rank of EBS is 9797
Overall Rank
The Sharpe Ratio Rank of EBS is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of EBS is 9696
Sortino Ratio Rank
The Omega Ratio Rank of EBS is 9595
Omega Ratio Rank
The Calmar Ratio Rank of EBS is 9898
Calmar Ratio Rank
The Martin Ratio Rank of EBS is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BSVO vs. EBS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for EA Bridgeway Omni Small-Cap Value ETF (BSVO) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BSVO, currently valued at 0.32, compared to the broader market0.002.004.000.323.40
The chart of Sortino ratio for BSVO, currently valued at 0.63, compared to the broader market0.005.0010.000.633.82
The chart of Omega ratio for BSVO, currently valued at 1.08, compared to the broader market0.501.001.502.002.503.001.081.53
The chart of Calmar ratio for BSVO, currently valued at 0.61, compared to the broader market0.005.0010.0015.000.616.21
The chart of Martin ratio for BSVO, currently valued at 1.41, compared to the broader market0.0020.0040.0060.0080.00100.001.4117.47
BSVO
EBS

The current BSVO Sharpe Ratio is 0.32, which is lower than the EBS Sharpe Ratio of 3.40. The chart below compares the historical Sharpe Ratios of BSVO and EBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025
0.32
3.40
BSVO
EBS

Dividends

BSVO vs. EBS - Dividend Comparison

BSVO's dividend yield for the trailing twelve months is around 1.59%, while EBS has not paid dividends to shareholders.


TTM202420232022202120202019201820172016
BSVO
EA Bridgeway Omni Small-Cap Value ETF
1.59%1.61%1.43%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBS
Emergent BioSolutions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%

Drawdowns

BSVO vs. EBS - Drawdown Comparison

The maximum BSVO drawdown since its inception was -12.52%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for BSVO and EBS. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025
-6.68%
-23.83%
BSVO
EBS

Volatility

BSVO vs. EBS - Volatility Comparison

The current volatility for EA Bridgeway Omni Small-Cap Value ETF (BSVO) is 3.96%, while Emergent BioSolutions Inc. (EBS) has a volatility of 15.06%. This indicates that BSVO experiences smaller price fluctuations and is considered to be less risky than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025
3.96%
15.06%
BSVO
EBS
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab